 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
 |
|
 |
|
|
|
 |
|
|
|
|
|
|
| |
| |
|
|
| |
|
| |
|
|
| |
| |
|
|
| |
The presence of anti-nuclear antibodies (ANA) occurs with high frequency in
systemic autoimmune diseases. When an autoimmune disorder is suspected the first
diagnostic step is the screening for ANAs. These antibodies, directed against
components of the cell nucleus and the cytoplasm, were first associated with
systemic lupus erythematosus (SLE), but the list of involved diseases has
widened because many rheumatic diseases are characterized by the presence of one
or more. The LIAISON® ANA Screen is used for the collective qualitative
determination of autoantibodies directed against the following antigens:
double-stranded DNA (dsDNA), RNP/Sm (70 kDa), SSA (Ro) (rich in 60 kDa), SS-B
(La), Scl-70, Jo-1, centromere (CENP-B) and mitochondria in human serum or
plasma, along with detection of sera positive for HEp-2 immunofluorescence
antibody test. This test is intended as an aid in the diagnosis of connective
tissue diseases (CTD), such as systemic lupus erythematosus (SLE), mixed
connective tissue disease (MCTD), Sjögren's syndrome (SS), systemic sclerosis
(Ssc), idiopatic polymyositis (PM), dermatomyositis (DM) and CREST syndrome. |
|
| |
|
|
| |
DiaSorin Liaison ANA Screen |
|
| |
- 2-step immunoluminometric sandwich assay using directly coated magnetic
microparticles
- Sample matrix: Serum, Plasma
- Sample volume: 20 µl
- Incubation time: 40 min
|
|
| |
|
Product code |
Product name |
Method |
Kit Size |
Sample Type |
|
310300 |
Liaison ANA Screen |
2-step immunoluminometric sandwich assay |
100 test kit |
Serum, Plasma |
|
N0093 |
ETI-ANA Screen |
ELISA |
96 wells |
Serum |
|
1662 / 1660 / 1624 / 6624 |
ANAFLUOR HEp-2 |
IFA |
10 x 6 wells
10 x 12 wells
20 x 12 wells
50 x 12 wells |
Serum |
|
1670 / 6670 |
ANAFAST HEp-2 |
IFA |
20 x 12 wells
50 x 12 wells |
Serum |
|
|
| |
|
|
|
|
|
Back To Top |
|
| |
| |
|
|
| |
Extractable nuclear antigens (ENA) are used for the screening of clinically
relevant RNP/Sm, SS-A (Ro), SSB (La), Scl-70, Jo-1 and centromere
(CENP-B) in human serum or plasma samples. Detection of ENA autoantibodies, as
well as the patient’s clinical picture, is helpful diagnostic tools for
evaluation of connective tissue diseases. |
|
| |
|
|
| |
DiaSorin Liaison ENA |
|
| |
- Competitive 2-step immunoluminometric sandwich assay using directly coated
magnetic microparticles
- Sample matrix: Serum, plasma
- Sample volume: 20 µl
- Incubation time: 40 minutes
|
|
| |
|
Product code |
Product name |
Method |
Kit Size |
Sample Type |
|
310330 |
Liaison ENA |
2-step immunoluminometric sandwich assay |
100 test kit |
Serum, plasma |
|
N0040 |
ETI-ENA 6 Screen |
ELISA |
96 wells |
Serum |
|
N0086 |
ETI-ENA 7 Screen |
ELISA |
96 wells |
Serum |
| N0041 |
ETI-ANA/ENA-8- Profile |
ELISA |
96 wells |
Serum |
|
|
|
|
| |
|
|
Back To Top |
|
| |
| |
|
|
| |
Anti-tissue Transglutaminase (tTg IgA) is used for the diagnosis of celiac
disease when symptoms like the following occur: chronic diarrhea, abdominal
pain, anemia, and weight loss; when an infant is chronically irritable or fails
to grow at a normal rate; when a family member has celiac disease; tTg IgG is
also used to monitor treatment of celiac disease . |
|
| |
|
|
| |
DiaSorin Liaison tTg IgA |
|
| |
- Competitive 2-step immunoluminometric sandwich assay using directly coated
magnetic microparticles
- Sample matrix: Serum, plasma
- Sample volume: 20 µl
- Incubation time: 40 minutes
- Measuring range: 0 – 800 AU/ml
|
|
| |
|
Product code |
Product name |
Method |
Kit Size |
Sample Type |
|
310320 |
Liaison tTG IgA |
2-step immunoluminometric sandwich assay |
100 test kit |
Serum, plasma |
|
|
| |
|
|
| |
Back To Top |
|
|
| |
| |
|
|
| |
Tests for IgG and IgM cardiolipin antibodies are frequently ordered to help
determine the cause of an unexplained thrombotic episode, recurrent miscarriage,
or thrombocytopenia. Cardiolipin antibodies may be ordered along with lupus
anticoagulant testing to help investigate the cause of a prolonged PTT
(activated partial thromboplastin time), especially if clinical findings suggest
that the patient may have SLE or another autoimmune disorder. |
|
| |
|
|
| |
DiaSorin Liaison Cardiolipin IgM |
|
| |
- Chemiluminescent indirect assay using directly coated magnetic microparticles
- Sample matrix: Serum, Plasma
- Sample volume: 10 µl
- Incubation time: 20 minutes
- Measuring range: 2 – 255 MPL U/ml
|
|
| |
DiaSorin Liaison Cardiolipin IgG |
|
| |
- Chemiluminescent indirect assay using directly coated magnetic microparticles
- Sample matrix: Serum, Plasma
- Sample volume: 10 µl
- Incubation time: 20 minutes
- Measuring range: 2 – 280 GPL U/ml
|
|
| |
|
Product code |
Product name |
Method |
Kit Size |
Sample Type |
|
310380 |
Liaison Cardiolipin IgM |
Chemiluminescent indirect assay |
50 test kit |
Serum, Plasma |
|
310370 |
Liaison Cardiolipin IgG |
Chemiluminescent indirect assay |
50 test kit |
Serum, Plasma |
|
N0057 |
ETI-Cardiolipin Screen |
ELISA |
96 wells |
Serum |
|
N0058 |
ETI-Cardiolipin IgM |
ELISA |
96 wells |
Serum |
|
N0059 |
ETI-Cardiolipin IgG |
ELISA |
96 wells |
Serum |
|
N0079 |
ETI-Cardiolipin IgA |
ELISA |
96 wells |
Serum |
|
|
|
|
| |
|
|
Back To Top |
|
| |
| |
|
|
| |
Antibodies against dsDNA belong to the group of Anti-Nuclear Antibodies (ANA),
which are directed against various structures of the cell nuclei. Antibodies to
dsDNA are a characteristic marker in patients with untreated active SLE –
occurring with a prevalence ranging from 40% to 80% – and correlate with the
onset of lupus nephritis. The presence of antibodies to dsDNA strongly indicates
SLE, but their absence does not rule out SLE in all cases. Low levels of
anti-dsDNA antibodies occur in other rheumatic diseases and, with a lower
frequency, in individuals asymptomatic for rheumatic disease. Several studies
report a correlation between disease activity and fluctuations in antibody
levels. Consequently, quantification of anti-dsDNA autoantibodies is of
paramount importance for clinical management of patients, e.g., for controlling
the course of the disease, for measuring disease activity (which is directly
related to circulating antibody titer), and for following up therapy outcome. |
|
| |
|
|
| |
DiaSorin Liaison dsDNA |
|
| |
- Competitive 2-step immunoluminometric sandwich assay using directly coated
magnetic microparticles
- Sample matrix: Serum, plasma
- Sample volume: 20 µl
- Incubation time: 40 minutes
- Measuring range: 0 – 240 IU/ml anti-dsDNA IgG
- Detection Limit: 0.4 mg/dl
|
|
| |
|
Product code |
Product name |
Method |
Kit Size |
Sample Type |
|
310310 |
Liaison dsDNA |
2-step immunoluminometric sandwich assay |
100 test kit |
Serum, plasma |
|
N0068 |
ETI-dsDNA |
ELISA |
96 wells |
Serum |
|
|
| |
|
|
| |
Back To Top |
|
|
| |
| |
|
|
| |
| Product code |
Product name |
Method |
Kit Size |
Sample Type |
| N0050 |
ETI-CENP-B |
ELISA |
96 wells |
Serum |
| N0055 |
ETI-Ribosomal P Proteins |
ELISA |
96 wells |
Serum |
| N0061 |
ETI-Jo-1 |
ELISA |
96 wells |
Serum |
| N0062 |
ETI-Histones |
ELISA |
96 wells |
Serum |
| N0063 |
ETI-Scl-70 |
ELISA |
96 wells |
Serum |
| N0064 |
ETI-Sm |
ELISA |
96 wells |
Serum |
| N0065 |
ETI-RNP/Sm |
ELISA |
96 wells |
Serum |
| N0066 |
ETI-SS-B (La) |
ELISA |
96 wells |
Serum |
| N0067 |
ETI-SS-A (Ro) |
ELISA |
96 wells |
Serum |
| N0078 |
ETI-ssDNA |
ELISA |
96 wells |
Serum |
| NU02-96 |
Nucleosome IgG ELISA |
ELISA |
96 wells |
Serum |
| N0056 |
ETI-Beta2 Glycoprotein I IgG |
ELISA |
96 wells |
Serum |
| N0077 |
ETI-Beta2 Glycoprotein I IgM |
ELISA |
96 wells |
Serum |
| N0081 |
ETI-Beta2 Glycoprotein I IgA |
ELISA |
96 wells |
Serum |
| N0053 |
ETI-p-ANCA/MPO |
ELISA |
96 wells |
Serum |
| N0054 |
ETI-c-ANCA/PR3 |
ELISA |
96 wells |
Serum |
| N0051 |
ETI-Mitochondrial |
ELISA |
96 wells |
Serum |
| N0092 |
ETI-LKM1 |
ELISA |
96 wells |
Serum |
| 6200 |
Complement Activation EIA (CAE) Kit |
ELISA |
96 wells |
Serum |
| 1790 / 1860 |
nDNA FLUORO-KIT Crithidia luciliae |
IFA |
10 x 5 wells
10 x 10 wells |
Serum |
| 1740 |
CT-3 Immuno Screen |
IFA |
10 x 6 wells |
Serum |
| 1741 |
CT-2 Immuno Screen |
IFA |
10 x 6 wells |
Serum |
| 1890/ 1770 |
RL FLUORO Screen |
IFA |
10 x 4 wells
10 x 8 wells
20 x 8 wells |
Serum |
| RA-96rt |
Immuno Screen RA |
ELISA |
96 wells |
Serum |
| 1970 |
RS FLUORO-KIT Rat Stomach |
IFA |
10 x 4 wells |
Serum |
|
|
| |
*Kit components are also available |
|
|
|
| |
|
|
|
|
|
Back To Top |
|
|
|
|
|
 |